Rheumatology
News from the FDA/CDC
Hypocalcemia Risk Warning Added to Osteoporosis Drug
Based on a completed data review, the agency concluded that denosumab increases the risk for severe hypocalcemia in patients with chronic kidney...
News
Musculoskeletal Symptoms Often Misattributed to Prior Tick Bites
A new study finds that Ehrlichia or Rickettsia seropositivity was not linked with chronic musculoskeletal symptoms, but alpha-...
News
Dieting and Gout: Intensive Weight Loss Not Especially Helpful for Symptoms
Researchers found an association between weight loss and a corresponding reduction in serum urate, but more weight loss did not result in positive...
News
Evidence Grows for SGLT2 Inhibitors in Rheumatology
Sodium-glucose cotransporter-2 (SGLT2) inhibitors are not approved to treat gout, lupus, or lupus nephritis, but clinicians are uncovering signs...
News
How to Reduce Cardiovascular Morbidity and Mortality in Psoriasis and PsA
Experts take a look at the landscape of why and how dermatologists and rheumatologists ought to play a more consistent and active role in primary...
News
Slow-to-moderate weight loss better than rapid with antiobesity drugs in OA
Rapid weight loss with antiobesity drugs had no significant impact on reduced mortality in a population-based study of more than 6000 adults with...
News
COVID vaccination protects B cell–deficient patients through T-cell responses
The findings demonstrate how vaccine-induced T-cell responses could potentially reduce COVID-19 severity, the authors write.
Conference Coverage
Study takes fine-grained look at MACE risk with glucocorticoids in RA
The level of risk for MACE rose with the dose, duration, and recency of GC use, and risk increased significantly at prednisone-equivalent doses as...
Conference Coverage
AI tool perfect in study of inflammatory diseases
A model that combines machine learning with clinical cues could help clinicians easily differentiate MIS-C from typhus, a new study found.
Conference Coverage
CPPD nomenclature is sore subject for gout group
G-CAN hopes to standardize terminology and finally oust ‘pseudo’ vernacular.